Published in Cancer Weekly, July 12th, 1999
In a previous study, researchers from the University of California/Mount Zion Cancer Center, California, demonstrated tumor regression in stage IV melanoma patients following vaccination with autologous tumor cells (ATCs) and recombinant human GM-CSF (rhGM-CSF) (SPL Leong et al., J of Immunotherapy, in press).
At the 35th Annual Meeting of the American Society of Clinical Oncology, held May...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.